What Articares does

Articares Pte Ltd is a Singapore-based medical devices company, founded in 2017 as a spin-off from Nanyang Technological University (NTU), that develops AI-powered portable rehabilitation robotics for stroke, neurological, and elderly rehabilitation. Its product portfolio comprises the H-Man portable upper-limb rehabilitation robot, the ReHandyBot hand and wrist rehabilitation robot developed with ETH Zurich, the ArmFlow arm support stand, and the CARE Platform - an intelligent rehabilitation dashboard and AI therapy analytics suite delivered via web and mobile apps that powers adaptive training, remote monitoring, and therapy feedback. Core technology centres on real-time AI-driven assessment of sensory, motor, cognitive and haptic performance, with an Adaptive Training Engine that automatically adjusts task complexity and assistance/resistance without continuous therapist intervention.

The company monetises primarily through capital equipment sales of its robotic devices to hospitals, neuro-rehabilitation centres, and physiotherapy clinics, supplemented by an H-Man home rental programme that creates recurring revenue from post-discharge patients and by CARE Platform software that is bundled with or sold alongside device deployments. Go-to-market combines direct enterprise sales via a 'Book a Demo' model, high-frequency participation in international healthcare exhibitions and stroke/rehabilitation congresses, and a strategic distribution partnership with Life Science Robotics ApS covering Austria, Germany, and Switzerland. Key clinical and academic partners include Tan Tock Seng Hospital, NTU, ETH Zurich's Rehabilitation Engineering Laboratory, Campus Biomedico di Roma, and Shirley-Ryan AbilityLab.

Articares operates an international footprint spanning Singapore (HQ), Pakistan (engineering), China (NMPA-approved H-Man sales), the DACH region via LSR, and selected EU/US sites, with regulatory approvals held in Singapore (HSA Class A for ArmFlow) and China (NMPA for H-Man). The only publicly disclosed capital inflow is an up to S$1.2 million project grant from Temasek Foundation and CHI through the Healthcare InnoMatch 2021 programme; no private equity or venture capital rounds are disclosed. Customer concentration is moderate, anchored by named hospital deployments such as Tan Tock Seng Hospital and by the LSR DACH channel, with no public revenue, ARR, or headcount figures disclosed.

Name

Articares

Legal name

Articares Pte Ltd

Website

https://articares.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Articares is a Singapore-based medical devices company developing AI-powered portable rehabilitation robots (H-Man, ReHandyBot) and the connected CARE Platform for stroke, neurological, and elderly rehabilitation across hospitals, clinics, and home-care settings.

Ownership category

akta.pro rank

Product category

Rehabilitation Robotics

NAICS

Home Health Care Services (62161), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Vocational Rehabilitation Services (62431)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industries

Healthcare & Assistive Robotics (HDAAAIAC), Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Assistive Technology, Adaptive Equipment & Home Exercise Program Training In-Home (HSABADAN)

Keywords

• Rehabilitation robotics
• AI therapy assessment
• Medical devices
• Neurorehabilitation robots
• Home rehabilitation

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Rehabilitation Robotics Hardware Sales: Articares sells its robotic rehabilitation devices (H-Man, ReHandyBot, ArmFlow) to hospitals, clinics, and community rehabilitation centers. These are capital equipment purchases for clinical use. The H-Man has received regulatory approvals from China's NMPA and Singapore's HSA (Class A for ArmFlow).
2. H-Man Home Rental Programme: Articares offers the H-Man device through a home rental programme, enabling patients to continue rehabilitation training in the comfort of their own homes. This provides recurring rental revenue from individual patients and extends the reach of the platform beyond institutional settings.
3. CARE Platform Software Licensing: The Care Platform software (web app and mobile app) provides remote monitoring, training planning, therapy feedback, and gamified rehabilitation exercises. The platform is designed for therapists and patients, likely sold as a subscription tied to device deployments or as a standalone SaaS license.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Articares designs, manufactures and sells AI-powered portable rehabilitation robots (H-Man arm robot, ReHandyBot hand/wrist robot) and an accessory support stand (ArmFlow), along with a software platform (CARE Platform) that delivers adaptive therapy, remote monitoring and analytics for clinical and home-based neurorehabilitation. Solutions target hospitals, rehabilitation clinics, community centers and home patients recovering from stroke, neurological and orthopaedic conditions.

Product overview

Articares offers a portfolio of AI-powered robotic rehabilitation solutions for clinical and home use. The core product line includes H-Man (portable arm rehabilitation robot) and ReHandyBot (hand and wrist rehabilitation robot), supported by the CARE Platform software which provides adaptive training, remote monitoring, and therapy analytics. ArmFlow is an accessory support stand designed to complement H-Man therapy. All products feature AI-driven assessment and adaptation capabilities, enabling minimally supervised use across the care continuum from hospital to home.

Differentiator

Problem solved

Functional benefit

Brands

• H-Man: AI-powered upper limb rehabilitation robot that adapts to patients' performance for personalized therapy. The world's first truly portable and clinically validated arm rehabilitation robot for hospitals, community centers, and homes.
• ReHandyBot
• ArmFlow
• CARE Platform

Products and services

• H-Man Arm Rehabilitation Robot AI-powered, portable, table-top arm rehabilitation robot that adapts exercises to each patient's performance and enables minimally supervised therapy in hospitals, community centres and homes. Designed for clinicians treating stroke, neurological and orthopaedic patients.
• ReHandyBot Hand and Wrist Rehabilitation Robot Hand and wrist rehabilitation robot that trains sensorimotor ability through true-to-life haptic representations of objects. Monitors haptic perception, sensorimotor coordination, cognitive capability and proprioception in real time and adapts exercises to each patient, with gamified therapy programs for increased engagement.
• ArmFlow Support Stand Independent Class A medical device support stand that compensates against gravity to support the affected arm during H-Man training or basic activities of daily living. Collapsible design for easy storage.
• CARE Platform AI-powered rehabilitation software platform providing Adaptive Training Engine, personalised Training Planner, Therapy Feedback Reports, Remote Monitoring via web and mobile apps, and a Games Library for gamified therapy. Used by therapists and patients in conjunction with Articares hardware for personalised therapy and remote monitoring.

Quantifiable outcome

• 65% improvement in therapist productivity — using H-Man enables therapists to cater to more patients on a regular basis while reducing departmental costs and increasing revenue
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Life Science Robotics ApS (LSR)coreChannel Partner/ Reseller/ Distributor · 1 January 2022Strategic partnership announced in 2022 where Articares handles distribution of Life Science Robotics' ROBERT® lower limb rehabilitation robot in Austria, Germany, and Switzerland. ROBERT® focuses on early mobilization and active resistive/assistive mobilization of lower extremities. Both companies exhibit together at major rehabilitation events. The partnership enables Articares to offer a complementary full-body rehabilitation solution in the DACH region. Articares' CCO Michael Frank stated the partnership would help explore new markets and joint technological development.
• Nanyang Technological University (NTU)coreStrategic or Co-development PartnerArticares is a spin-off from NTU. Co-founder Domenico Campolo is Director of the Robotics Research Centre at NTU's School of Mechanical and Aerospace Engineering. The H-Man arm rehabilitation robot was developed in collaboration with NTU and Tan Tock Seng Hospital.
• Tan Tock Seng Hospital (TTSH)coreStrategic or Co-development PartnerClinical development partner for the H-Man. Articares was paired with TTSH in the Healthcare InnoMatch 2021 programme to implement a home-based telerehabilitation solution. TTSH has featured Articares' technology in clinical settings and媒体报道.
• ETH Zurich (Rehabilitation Engineering Laboratory)coreStrategic or Co-development PartnerThe ReHandyBot was developed in close partnership with the Rehabilitation Engineering Laboratory (RELab) at ETH Zurich and Clinica Hildebrand Centro di riabilitazione Brissago, Switzerland. This partnership represents over 15 years of advanced research on technology-based hand rehabilitation. Prof. Roger Gassert of ETH Zurich contributed to the ReHandyBot's haptic feedback design.
• Temasek Foundation / Centre for Healthcare Innovation (CHI)minorStrategic or Co-development PartnerArticares won Healthcare InnoMatch 2021, a programme organized by Temasek Foundation and CHI. Articares received up to S$1.2m in project funding and was paired with Tan Tock Seng Hospital for a home-based telerehabilitation pilot on the H-Man platform.
• Imperial College LondonminorStrategic or Co-development PartnerCEO Asif Hussain studied and worked at Imperial College London, applying expertise in human-machine interaction to Articares' product development.
• Shirley-Ryan AbilityLabminorStrategic or Co-development PartnerStrategic institutional partner listed on Articares' About page, indicating collaboration in rehabilitation research and clinical technology development.
• Campus Biomedico di RomaminorStrategic or Co-development PartnerListed as a strategic partner on Articares' About page, indicating collaboration in clinical and rehabilitation technology research.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Saebo: US-based provider of upper-limb rehabilitation devices and digital therapy tools (SaeboStim, SaeboVR, SaeboRejoyce) used across hospital and home settings. Comparable in targeting stroke rehab, therapist augmentation, and home extension.
• MindMaze: Digital neurotherapeutics platform combining VR, gamified exercises and AI-based assessment for stroke and brain injury rehab. Comparable through its CARE-like software/AI therapy analytics approach, though more digital than robotic.

Direct peers

• Tyromotion: Austrian manufacturer of robotic and mechatronic therapy devices (Diego, Amadeo, Pablo, Lexo) for upper-limb and hand rehabilitation. Closest direct competitor to H-Man and ReHandyBot in technology, customer base, and clinic setting.
• Hocoma (DIH Medical): Global market leader in robotic and sensor-based rehabilitation devices (Armeo, Erigo, Lokomat). Directly competes with Articares in upper-limb rehabilitation robotics for hospitals and clinics.
• Bionik Laboratories: Provider of the InMotion ARM and InMotion HAND robots for upper-limb neurorehabilitation, with cloud-based analytics. Directly comparable to H-Man and ReHandyBot in clinical use case, target customers, and adaptive therapy technology.
• Fourier Intelligence: Shanghai-based rehabilitation robotics company offering ArmMotus, HandyRehab and other upper/lower-limb devices with AI-driven assessments. Comparable to Articares in APAC focus, AI-adaptive therapy, and clinical validation story.
• Motorika: Israeli developer of robotic rehabilitation devices (ReoGo, ReoAmbulator) for upper and lower extremity therapy. Comparable clinical customer base and AI-enhanced therapy positioning.
• Life Science Robotics: Danish maker of the ROBERT lower-limb rehabilitation robot and Articares' strategic DACH distribution partner. Directly comparable rehabilitation robotics technology and clinical positioning, and the partnership makes it a tightly coupled peer.

Broad incumbents

• ReWalk Robotics: Public exoskeleton and soft-robotic rehabilitation company (ReWalk, Restore). Operates in adjacent rehabilitation robotics markets with focus on gait/lower-limb rather than upper-limb tabletop devices.
• Ekso Bionics: Public rehabilitation and exoskeleton company (EksoNR, Ekso Indego) serving stroke and spinal cord injury markets. Operates broadly in clinical rehabilitation robotics but with focus on lower-limb/gait rather than upper-limb tabletop devices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ARTICARES
• Facebookfacebook.com/realArtiCares
• LinkedInlinkedin.com/company/articares

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Articares